# HeartSciences Inc.: filings

HSCS · Nasdaq · CIK 1468492 · [Financials](/sectors/financials.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/hscs.md) · [Financials](/companies/hscs/financials.md) · [Filings](/companies/hscs/filings.md) · [Insiders](/companies/hscs/insiders.md)

## Reports and events: 136 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 93, DEFA14A 71, 4 28, 424B3 18, 10-Q 13, D 13, CORRESP 11, UPLOAD 9, 3 7, 8-K/A 7, S-1/A 6, 10-K 5, 424B5 5, EFFECT 5, S-1 5, 253G2 4, SC 13G 4, DEF 14A 3, S-8 3, DRS 2, PRE 14A 2, PRER14A 2, QUALIF 2, RW 2, S-3 2, SC 13D 2, SCHEDULE 13G 2, 144 1, 1-A 1, 1-A/A 1, 1-A POS 1, 424B4 1, 8-A12B 1, CERT 1, D/A 1, DEFM14A 1, DRS/A 1, DRSLTR 1, FWP 1, POS EX 1, PREM14A 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 21:30 ET | [SCHEDULE 13D/A](/filings/0001213900-26-112224.md) | Ownership report, active investor, amended | 0001213900-26-112224 |
| 2026-10-06 | 16:30 ET | [8-K](/filings/0001213900-26-107238.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-107238 |
| 2026-10-02 | 17:15 ET | [8-K](/filings/0001213900-26-106500.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-26-106500 |
| 2026-09-17 | 08:01 ET | [8-K](/filings/0001213900-26-100752.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-100752 |
| 2026-09-15 | 17:02 ET | [8-K](/filings/0001213900-26-100185.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-100185 |
| 2026-09-14 | 16:14 ET | [10-Q](/filings/0001437749-26-030319.md) | Quarterly report, period 2026-07-31 | 0001437749-26-030319 |
| 2026-08-20 | 07:43 ET | [8-K](/filings/0001213900-26-091893.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-091893 |
| 2026-08-19 | 17:11 ET | [8-K/A](/filings/0001213900-26-091764.md) | 9.01 Financial statements and exhibits | 0001213900-26-091764 |
| 2026-08-19 | 16:45 ET | [8-K](/filings/0001213900-26-091720.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-091720 |
| 2026-08-18 | 20:13 ET | [SCHEDULE 13D](/filings/0001213900-26-091367.md) | Ownership report, active investor | 0001213900-26-091367 |
| 2026-08-18 | 17:13 ET | [8-K](/filings/0001213900-26-091301.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-091301 |
| 2026-08-07 | 17:00 ET | [8-K](/filings/0001213900-26-086773.md) | 3.01 Delisting notice | 0001213900-26-086773 |
| 2026-07-29 | 09:00 ET | [8-K](/filings/0001213900-26-082577.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-082577 |
| 2026-07-27 | 16:30 ET | [8-K/A](/filings/0001213900-26-081833.md) | 9.01 Financial statements and exhibits | 0001213900-26-081833 |
| 2026-07-27 | 16:26 ET | [8-K](/filings/0001213900-26-081825.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-081825 |
| 2026-07-23 | 17:20 ET | [8-K](/filings/0001213900-26-081007.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-081007 |
| 2026-07-23 | 16:48 ET | [10-K](/filings/0001437749-26-024337.md) | Annual report, period 2026-04-30 | 0001437749-26-024337 |
| 2026-07-10 | 17:00 ET | [8-K](/filings/0001213900-26-077218.md) | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-077218 |
| 2026-06-26 | 17:22 ET | [8-K](/filings/0001213900-26-072722.md) | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-072722 |
| 2026-06-23 | 17:16 ET | [8-K](/filings/0001213900-26-071186.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-071186 |
| 2026-06-23 | 08:33 ET | [8-K](/filings/0001213900-26-070862.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-070862 |
| 2026-05-06 | 17:00 ET | [8-K](/filings/0001213900-26-052872.md) | 5.07 Shareholder vote results | 0001213900-26-052872 |
| 2026-04-03 | 17:15 ET | [8-K](/filings/0001213900-26-040032.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-040032 |
| 2026-03-17 | 16:16 ET | [DEF 14A](/filings/0001213900-26-029099.md) | Proxy statement, period 2026-04-30 | 0001213900-26-029099 |
| 2026-03-16 | 16:15 ET | [8-K](/filings/0001437749-26-008420.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-008420 |
| 2026-03-16 | 16:04 ET | [10-Q](/filings/0001437749-26-008399.md) | Quarterly report, period 2026-01-31 | 0001437749-26-008399 |
| 2026-01-16 | 17:15 ET | [8-K](/filings/0001213900-26-005245.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-005245 |
| 2025-12-16 | 16:34 ET | [8-K](/filings/0001193125-25-320983.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-320983 |
| 2025-12-15 | 16:17 ET | [8-K](/filings/0001193125-25-319234.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-319234 |
| 2025-12-15 | 16:11 ET | [10-Q](/filings/0001193125-25-319203.md) | Quarterly report, period 2025-10-31 | 0001193125-25-319203 |
| 2025-11-28 | 17:10 ET | [8-K](/filings/0001213900-25-116128.md) | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-116128 |
| 2025-10-01 | 17:23 ET | [8-K](/filings/0001193125-25-227023.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-227023 |
| 2025-09-17 | 16:47 ET | [8-K](/filings/0001193125-25-206295.md) | 3.01 Delisting notice | 0001193125-25-206295 |
| 2025-09-11 | 16:28 ET | [8-K](/filings/0001468492-25-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001468492-25-000011 |
| 2025-09-11 | 16:04 ET | [10-Q](/filings/0001468492-25-000010.md) | Quarterly report, period 2025-07-31 | 0001468492-25-000010 |
| 2025-09-08 | 19:19 ET | [8-K](/filings/0001468492-25-000006.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001468492-25-000006 |
| 2025-08-22 | 16:09 ET | [8-K](/filings/0001468492-25-000003.md) | 8.01 Other events | 0001468492-25-000003 |
| 2025-08-04 | 08:30 ET | [8-K](/filings/0001213900-25-070889.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-070889 |
| 2025-07-30 | 16:39 ET | [8-K](/filings/0000950170-25-100335.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-100335 |
| 2025-07-24 | 16:17 ET | [8-K](/filings/0000950170-25-098346.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-098346 |
| 2025-07-24 | 16:05 ET | [10-K](/filings/0000950170-25-098326.md) | Annual report, period 2025-04-30 | 0000950170-25-098326 |
| 2025-07-21 | 16:56 ET | [8-K](/filings/0000950170-25-097293.md) | 8.01 Other events | 0000950170-25-097293 |
| 2025-07-14 | 09:00 ET | [8-K](/filings/0001213900-25-063491.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-063491 |
| 2025-07-01 | 17:15 ET | [8-K](/filings/0001213900-25-060467.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-25-060467 |
| 2025-06-04 | 09:00 ET | [8-K](/filings/0000950170-25-081410.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-081410 |
| 2025-06-04 | 18:30 ET | [8-K](/filings/0000950170-25-081197.md) | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-081197 |
| 2025-06-03 | 09:00 ET | [8-K](/filings/0000950170-25-080578.md) | 8.01 Other events | 0000950170-25-080578 |
| 2025-05-28 | 16:51 ET | [8-K](/filings/0000950170-25-078404.md) | 5.03 Amendment to articles or bylaws | 0000950170-25-078404 |
| 2025-05-19 | 17:29 ET | [8-K](/filings/0000950170-25-074598.md) | 3.01 Delisting notice; 8.01 Other events | 0000950170-25-074598 |
| 2025-03-21 | 17:15 ET | [8-K](/filings/0001013762-25-001087.md) | 3.01 Delisting notice | 0001013762-25-001087 |

Page 1 of 3. [Older](/companies/hscs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:27 ET. No prices; not investment advice.